Blenrep Approved by US FDA for Use in Treatment of Relapsed/Refractory Multiple Myeloma

Oct 24, 2025 - 01:00
 0  1
London, UK October 23, 2025 GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of adult...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0